Retinoids in cancer chemoprevention

FASEB Journal

Volumn 10, Issue 9, 1996, Pages 1031-1039

  Lotan, Reuben ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

cancer prevention; premalignant lesion; retinoic acid

Indexed keywords

ALITRETINOIN; ALPHA INTERFERON; BETA CAROTENE; COLECALCIFEROL; ETRETIN; ETRETINATE; FENRETINIDE; ISOTRETINOIN; OLTIPRAZ; PHORBOL 13 ACETATE 12 MYRISTATE; POLYPRENOIC ACID; RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOID; RETINOID DERIVATIVE; RETINOL; RETINOL DERIVATIVE; RETINOL PALMITATE; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER PREVENTION; CANCER RISK; CHEILITIS; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG MIXTURE; DRY SKIN; GASTROINTESTINAL CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; INTRAVAGINAL DRUG ADMINISTRATION; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRECANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINOL DEFICIENCY; REVIEW; SECOND CANCER; SKIN CARCINOMA; TERATOGENICITY; TOPICAL DRUG ADMINISTRATION; UTERINE CERVIX CARCINOMA;

EID: 0029796637     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.10.9.8801164     Document Type: Review

References (47)

1. Creenwald, P., Kelloff, G., Burch-Whitman, C., and Kramer, B. S. (1995) Chemoprevention. CA Cancer J. Clin. 45, 31-49
2. Hong, W. K., and Itri, L. M. (1994) Retinoids and human cancer. In The Retinoids (Sporn, M. B., Roberts, A. B., and Goodman, D. S., eds) pp. 597-658, Raven Press, New York
3. Hong, W. K., Lippman, S. M., Hittelman, W. N., and Lotan, R. (1995) Retinoid chemoprevention of aerodigeslive cancer: from basic research to the clinic. Clin. Cancer Res. 1, 677-686
4. Lippman, S. M., Benner, S. E., and Hong, W. K. (1995) The chemoprevention of cancer. In Cancer Prevention and Control (Greenwald, P., Kramer, R. S., and Weed, D. L., eds) pp. 329-352, Marcel Dekker, New York
5. Moon, R. C., Mehta, R. G., and Rao, K. J. V. N. (1994) Retinoids and cancer in experimental animals. In The Retinoids (Sporn, M. B., Roberts, A. B., and Goodman, D. S., eds) pp. 573-595, Raven Press, New York
6. De Palo, G., Veronesi, U., Camerini, T., Formelli, F., Mascotti, G., Boni, C., Fosser, V., Del Vecchio, M., Campa, T., Costa, A., and Marubini, E. (1995) Can fenretinide protect women against ovarian cancer? J. Natl. Cancer Inst. 87, 146-147
7. Bertram, J. S. (1983) Inhibition of neoplastic transformation in vitro by retinoids. Cancer Surv, 3, 243-262
8. Harisiadis, L., Miller, R. C., Hall, E. J., and Borek, C. (1978) A vitamin A analogue inhibits radiation-induced oncogene transformation. Nature (London) 174, 186-287
9. Steele, V. E., Kelloff, C. J., Wilkinson, B. P., and Arnold, J. T. (1990) Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents. Cancer Res. 50, 2068-2074
10. Lotan, R. (1995) Cellular biology of the retinoids. In Retinoids in Oncology (Degos, L., and Parkinson, D. R., eds) pp. 27-42, Springer, Berlin
11. Creek, K. E., Jenkins, G. R., Khan, M. A., Batova, A., Hodam, J. R., Tolleson, W. H., and Pirisi, L. (1994) Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes. Adv. Exp. Med. Biol. 354, 19-35
12. Shindoh, M., Sun, Q., Pater, A., and Pater, M. M. (1995) Prevention of carcinoma in situ of human papillomavirus type-16-immortalized human endocervical cells by retinoic acid in organotypic raft culture. Obstet. Gynecol. 85, 721-728
13. Verma, A. K. (1992) Ornithine decarboxylase, a possible target for human cancer prevention. In Cellular and Molecular Targets for Chemoprevention (Steele, V. E., Boone, C., and Kelloff, C., eds) pp. 207-224, CRC Press, Boca Raton, Florida
14. De Luca, L. M., Darwiche, N., Celli, G., Kosa, K., Jones, C., and Ross, S. (1994) Vilamin A in epithelial differentiation and skin carcinogenesis. Nutr. Rev. 52, 45-52
15. Athar, M., Agarwal, R., Wang, Z. Y., Lloyd, J. R., Bickers, D. R., and Mukhtar, H. (1991) All-trans retinoic acid protects against conversion of chemically induced and ultraviolet B radiation-induced skin papillomas to carcinomas. Carcinogenesis 12, 2325-2329
16. Marks, S. L., Song, M. D., Stannard, A. A., and Power, H. T. (1992) Clinical evaluation of etretinate for the treatment of canine solar-induced squamous cell carcinoma and preneoplastic lesions. J. Am. Acad. Dermatol. 27, 11-16
17. Auzano, M. A., Byers, S. W., Smith, J. M., Peer, C. W., Mullen, L. T., Brown, C. C., Roberts, A. B., and Sporn, M. B. (1994) Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. Cancer Res. 54, 4614-4617
18. Shklar, G., Schwartz, J., Grau, D., Trickler, D. P., and Wallace, K. D. (1980) Inhibition of hamster buccal pouch carcinogenesis by 13-cis-retinoic acid. Oral Surg. 50, 45-52
19. Inoue, I., Yamamoto, Y., Ito, T., and Takahashi, H. (1993) Chemoprevention of tongue carcinogenesis in rats. Oral Surg. Oral Med. Oral Pathol. 876, 608-615
20. Wargovich, M. J., Chen, C. D., Harris, C., Yang, E., and Velasco, M. (1995) Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. Int. J. Cancer 60, 515-519
21. Muto, Y., Ninomiya, M., and Fujiki, H. (1990) Present status of research on cancer chemoprevention in Japan. Jpn. J. Clin. Oncol. 20, 219-220
22. Pollard, M., Luckert, P. H., and Sporn M. B. (1991) Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res. 51, 3610-3611
23. Slawin, K., Kadinon, D., Park, S. H., Scardino, P. T., Anzuno, M., Sporn, M. B., and Thompson, T. C. (1993) Dietary Fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras- myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res. 53, 4461-4465
24. Han, J. (1993) Highlights of the cancer chemoprevention studies in China. Prev. Med. 22, 712-722
25. Moon, T. E., Cartmel, B., Levine, N., Bangert, J., and Peng, Y. M. (1993) (Chemoprevention and etiology of non-melanoma skin cancers. Proc. Am. Soc. Prev. Oncol. (abstr.)
26. Bavinek, J. N., Tieben, L. M., Van der Woude, F. J., Tegzess, A. M., Hermans, J., Schegget, J., and Vermeer, B. J. (1995) Prevention of skin cancer and reduction of keralotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J. Clin. Oncol. 13, 1933-1938
27. Hook, A. H., Jaworsky, C., Nguyen, T., Grossman, R. A., Wolfe, J. T., Wilmer, W. K., and Kligman, A. M. (1995) Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. Transplantation 59, 714-719
28. Edwards, L., and Jaffe, P. (1990) The effects of topical tretinoin on dysplastic nevi. Arch. Dermatol. 126, 494-499
29. Halpern, A. C., Schuchter, L. M., Elder, D. E., Guerry, D., IV, Elenitsas, R., Trock, B., and Matozzo, I. (1994) Effects of topical tretinoin on dysplastic nevi. Clin. Oncol. 12, 1028-1035
30. Beenken, S. W., Huang, P., Sellers, M., Peters, G., Listinsky, C., Stockard, C., Hubbard, W., Wheeler, R., and Grizzle, W. (1994) Retinoid modulation of biomarkers in oral leukoplakia/dysplasia. J. Cell. Biochem. (Suppl.) 19, 270-277
31. Chiesa, F., Tradati, N., Maraaza, M., Rossi, N., Boracchi, P., Mariani, L., Formelli, F., Giardini, R., Costa, A., De Palo, G., and Veronesi, U. (1993) Fenretinide (4-HPR) in chemoprevention of oral leukoplakia. J. Cell. Biochem. (Suppl.) 17F, 255-261
32. Custa, A., Formelli, F., Chiesa, F., Decensi, A., De Palo, G., and Veronesi, U. (1994) Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res. (Suppl.) 54, 2032s-2037s
33. Lee, J. S., Lippman, S. M., Benner, S. E., Lee, J. J., Ro, J. Y., Lukeman, J. M., Morice, R. C., Peters, E. J., Pang, A. C., Fritsche, H. A., Jr., and Hong, W. K. (1994) Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J. Clin. Oncol. 12, 937-915
34. Meyskens, F. L., Surwit, E, Moon, T. E., Childers, J. M., Davis, J. R., Dorr, R. T., Johnson, C. S., and Alberts, D. S. (1994) Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J. Natl. Cancer Inst. 86, 539-543
35. Peek, G. L., and DiGiovanna, J. J. (1994) Synthetic retinoids in dermatology. In The Retinoids (Sporn, M. B., Roberts, A. B., and Goodman, D. S., eds) pp. 631-658, Raven Press, New York
36. Bolla, M., Lefur, R., Ton Van, J., Domenge, C., Badet, J. M., Koskas, Y., and Laplanche, A. (1994) Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study. Eur. J. Cancer 30A, 767-772
37. Pastorino, U., Infante, M., Maioli, M., Chiesa, G., Buyse, M., Pirket, P., Rosementz, N., Clerici, M., Soresi, E., Valente, M., Belloni, P. A., and Ravasi, G. (1993) Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J. Clin. Oncol. 11, 1216-1222
38. Prout, G. R., Jr., and Barton, B. A. (1992) 13-cis-retinoic acid in chemoprevention of superficial bladder cancer. The National Bladder Cancer Group. J. Cell. Biochem. (Suppl.) 161, 148-52
39. Studer, U. E., Jenzer, S., Biedermann, C., Chollet, D., Kraft, R., Vontoggenburg, H., and Vonbank, F. (1995) Adjuvant treatment with vitamin A analogue (etretinate) after transurethral resection of superficial bladder tumors - final analysis of a prospective randomized multicenter trial in Switzerland. Eur. Urol. 28, 284-290
40. Lotan, R. (1995) Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst. 87, 1655-1657
41. Darwiche, N., Celli, C., Tennenbaum, T., Glick, A. B., Yuspa, S. H., and De Luca, L. M. (1995) Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Cancer Res. 55, 2774-2782
42. Kumar, R., Shoemaker, A. R., and Verma, A. K. (1994) Retinoic acid nuclear receptors and tumor promotion: decreased expression of retinoic acid nuclear receptors by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 15, 701-705
43. Xu, X-C., Wong, W. Y. L., Goldberg, L. H., Baer, S., Wolf, J. E., and Lotan, R. (1996) Suppression of nuclear retinoid receptor expression in squamous cell carcinomas of the skin. Proc. Am. Assoc. Cancer Res. 37, 232 (abstr.)
44. Xu, X.-C., Ro, J. Y., Lee, J. S., Shin, D. M., Hong, W. K., and Lotan, R. (1994) Differential expression of nuclear retinoic acid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res. 54, 3580-3587
45. Lotan, R., Xu, X.-C., Lippman, S. M., Ro, J. Y., Lee, J. S., Leo, J. J., and Hong, W. K. (1995) Suppression of retinoic acid receptor β in oral premalignant lesions and its upregulation by isotretinoin. N. Engl. J. Med. 332, 1405-1410
46. Pfahl, M. (1993) Nuclear receptor/AP-1 interaction. Endocr. Rev. 14, 651-658
47. Li, J. J., Dong, Z. C., Dawson, M. I., and Colbum, N. H. (1996) Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res. 56, 483-489